During the past decade, Atlantis Retina Institute (Atlantis Eyecare) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Atlantis Retina Institute (Atlantis Eyecare)" are "Macular Degeneration" (3 trials). Many other conditions were trialed in "Atlantis Retina Institute (Atlantis Eyecare)" in a lesser frequency.

Most popular intervention types in "Atlantis Retina Institute (Atlantis Eyecare)" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abicipar pegol" (2 trials), "Abicipar Pegol" (1 trials), "Ranibizumab" (1 trials) and "Sham Procedure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atlantis Retina Institute (Atlantis Eyecare)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Atlantis Retina Institute (Atlantis Eyecare)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Atlantis Retina Institute (Atlantis Eyecare), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Atlantis Retina Institute (Atlantis Eyecare), 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".